Answers are grounded in this paper and cite their sources.
Methyl jasmonate demonstrates protective effects against oxidative damage in diabetic rats, suggesting potential therapy.
This study evaluated the potential of methyl jasmonate (MeJA) to modulate oxidative stress damage and hyperglycemia in rats with STZ-induced diabetes. MeJA treatment (5 and 10 mg/kg) improved the destructive effects of STZ-induced oxidative damage, as proved by the decline in ROS formation and lipid peroxidation. In addition, MeJA displayed a substantial upsurge in the level of tissue GSH and activity of CAT and SOD enzymes. Histological analysis confirmed MeJA alleviated liver damage. Given the crucial part oxidative stress plays in the etiology of diabetes, this study offers a novel viewpoint on MeJA's potential as a treatment.
No takes yet. Share an insight, caveat, or question.
Shabazi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: